Dynavax Technologies Corp (DVAX)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

2100 POWELL STREET EMERYVILLE, CA 94608

Dynavax is a commercial stage biopharmaceutical company developing and commercializing novel vaccines. The Company's commercial product, HEPLISAV-B® [Hepatitis B Vaccine (Recombinant), Adjuvanted], is approved in the U.S. for prevention of infection caused by all known subtypes of hepatitis B virus in adults age 18 years and older. Dynavax is also advancing CpG 1018 as a premier vaccine adjuvant through research collaborations and partnerships. Current collaborations are focused on adjuvanted vaccines for COVID-19, pertussis and universal influenza.

Data as of 2021-08-02 07:44:38 -0400
Market Cap1.07 Billion Shares Outstanding114.588 Million Avg 30-day Volume1.398 Million
P/E Ratio-17.3113 Dividend Yield EPS-0.57
Price/Sales9.0 Debt to Equity4.91 EBITDA-19.801 Million
Price to Book Value10.73 Forward PE0.13 Enterprise Value1.017 Billion
Total Cash232.674 Million Current Debt109.422 Million Gross Profit85.084 Million
BETA2.00845 52-week High/Low11.84 / 3.58 Next Earnings Date2021-08-04 Price to Cash FLow (P/CF) 1253.4955
Data provided by IEX Cloud
View SEC Filings from DVAX instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 1 2 -50.0% 0 (0.0%) 1 (0.06%) -100.0%
Funds Holding: 159 143 11.19% 37 (2.17%) 33 (1.92%) 12.12%
13F shares: 83.832 Million 84.103 Million -0.32% 15.5 Million 14.663 Million 5.71%
% Ownership 74.0197 76.3374 -3.04% 13.6855 13.3088 2.83%
New Positions: 36 12 200.0% 9 4 125.0%
Increased Positions 47 53 -11.32% 13 10 30.0%
Closed Positions 19 31 -38.71% 5 18 -72.22%
Reduced Positions 51 43 18.6% 11 15 -26.67%
Total Calls 2.78 Million 661.73 Thousand 320.13% 520.192 Thousand 140.8 Thousand 269.45%
Total Puts 1.219 Million 800.924 Thousand 52.16% 298.2 Thousand 74.7 Thousand 299.2%
PUT/CALL Ratio 0.44 1.21 -63.64% 0.57 0.53 7.55%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Dynavax Technologies Corp YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding DVAX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding DVAX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

2.9 Million total shares from 1 transactions

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

HACK ANDREW A. F.

  • Director
 12,665,000 2021-06-10 2

PHILLIPS PEGGY V

  • Director
 25,000 2021-05-28 1

CANO FRANCIS

  • Director
 25,000 2021-05-28 1

KISNER DANIEL L

  • Director
 25,000 2021-05-28 1

RICCIARDI NATALE S

  • Director
 25,000 2021-05-28 1

EASTLAND JULIA MARIE

  • Director
 25,000 2021-05-28 1

MACGREGOR BRENT

  • Director
 25,000 2021-05-28 1

PARADISO PETER R.

  • Director
 18,750 2021-05-28 3

NOVACK DAVID F PRESIDENT & COO

  • Officer
 117,399 2021-04-01 2

JANSSEN ROBERT SENIOR VICE PRESIDENT

  • Officer
 86,861 2021-03-12 3

MACDONALD KELLY SVP AND CFO

  • Officer
 0 2021-03-01 2

BURGESS JUSTIN PRINCIPAL ACCOUNTING OFFICER

  • Officer
 33,718 2021-02-26 3

SPENCER RYAN CEO AND DIRECTOR

  • Officer
  • Director
 90,453 2021-02-22 2

OSTRACH MICHAEL S SENIOR VICE PRESIDENT

  • Officer
 0 2021-02-03 1

ORONSKY ARNOLD L

  • Director
 0 2020-05-28 0

JOHNSON DAVID LOUIS VICE PRESIDENT

  • Officer
 48,380 2020-03-13 0

COFFMAN ROBERT SENIOR VICE PRESIDENT

  • Officer
 77,768 2019-06-02 0

GRAY EDDIE CEO AND DIRECTOR

  • Officer
  • Director
 304,597 2019-06-02 0

CARSON DENNIS

  • Director
 0 2019-05-30 0

BREGE LAURA

  • Director
 0 2019-05-30 0

PLOTKIN STANLEY A

  • Director
 0 2017-06-02 0

DINA DINO

  • Director
 0 2014-05-28 0

GILBERT DENISE

  • Director
 0 2014-05-28 0

LEW JENNIFER VP, FINANCE & PAO

  • Officer
 0 2013-02-05 0

TUCK STEPHEN F VP, GLOBAL TECHNICAL OPS

  • Officer
 0 2013-02-05 0

MARTIN J TYLER PRESIDENT, CMO & DIRECTOR

  • Officer
  • Director
 222,089 2012-11-16 0

KESSEL MARK

  • Director
 3,031,431 2012-10-16 0

LARSON CHRISTINE R VP AND CHIEF FINANCIAL OFFICER

  • Officer
 0 2012-08-13 0

JANOWICZ ZBIGNIEW CEO DYNAVAX EUROPE

  • Officer
 0 2012-03-09 0

BUC NANCY L

  • Director
 0 2010-05-12 0

LAWRENCE DAVID M

  • Director
 0 2010-05-12 0

SYMPHONY CAPITAL PARTNERS LP

SYMPHONY CAPITAL GP, L.P.

SYMPHONY GP, LLC

SYMPHONY STRATEGIC PARTNERS LLC

TARANTO HARRI V

  • Director
  • 10% Owner
  • SEE FOOTNOTE 5 AND REMARKSSEE FOOTNOTE 5 AND REMARKSSEE FOOTNOTE 5 AND REMARKSSEE FOOTNOTE 5 AND REMARKSSEE FOOTNOTE 5 AND REMARKS
 9,031,431 2010-04-16 0

BVF PARTNERS L P/IL

BIOTECHNOLOGY VALUE FUND L P

BIOTECHNOLOGY VALUE FUND II LP

BVF INVESTMENTS LLC

LAMPERT MARK N

BVF INC/IL

  • 10% Owner
  • DIRECT BENEFICIAL OWNERDIRECT BENEFICIAL OWNERDIRECT BENEFICIAL OWNER
17,115,404 2009-09-10 0

BVF PARTNERS L P/IL

BIOTECHNOLOGY VALUE FUND L P

BIOTECHNOLOGY VALUE FUND II LP

BVF INVESTMENTS LLC

BVF INC/IL

  • 10% Owner
  • INDIRECT BENEFICIAL OWNERDIRECT BENEFICIAL OWNERDIRECT BENEFICIAL OWNERDIRECT BENEFICIAL OWNERINDIRECT BENEFICIAL OWNER
 25,254,628 2009-06-03 0

SMELTZER DEBORAH A VP, OPERATIONS & CFO

  • Officer
 0 2009-03-10 0

FLYNN JAMES E

DEERFIELD CAPITAL LP

DEERFIELD SPECIAL SITUATIONS FUND, L.P.

DEERFIELD MANAGEMENT CO /NY

DEERFIELD SPECIAL SITUATIONS FUND INTERNATIONAL LTD

DEERFIELD PRIVATE DESIGAN FUND L P

DEERFIELD PRIVATE DESIGN INTERNATIONAL, L.P.

  • 10% Owner
 No longer subject to file 2008-10-22 0

SANDERS MARTIN E EVP AND CDO

  • Officer
 0 2008-10-03 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

HACK ANDREW A. F. - Director see footnotes

2021-06-11 17:23:23 -0400 2021-06-10 S 2,916,250 d 0 indirect

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund DVAX -30.0 shares, $-294.9 2021-03-31 N-PORT
RUSSELL INVESTMENT FUNDS- U.S. Small Cap Equity Fund DVAX -1035.0 shares, $-10174.05 2021-03-31 N-PORT
RUSSELL INVESTMENT CO- U.S. Small Cap Equity Fund DVAX -6227.0 shares, $-62145.46 2021-04-30 N-PORT
Franklin Alternative Strategies Funds- Franklin K2 Alternative Strategies Fund DVAX -68781.0 shares, $-564004.2 2021-05-28 N-PORT

Elevate your investments